BHCM
NVAX icon

Brevan Howard Capital Management’s Novavax NVAX Stock Holding History

Brevan Howard Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
69,815
+17,176
+33% +$154K ﹤0.01% 1300
2026
Q1 		$428K Sell
52,639
-218,460
-81% -$1.98M ﹤0.01% 1396
2025
Q4 		$1.82M Buy
+271,099
New +$2.04M 0.02% 517
2024
Q4 		– Sell
-12,413
Closed -$157K – 1316
2024
Q3 		$157K Sell
12,413
-51,107
-80% -$660K ﹤0.01% 1036
2024
Q2 		$804K Buy
+63,520
New +$639K 0.01% 443

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Brevan Howard Capital Management's NVAX Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Novavax (NVAX) stake by 33% in Q2 2026, buying an estimated $154K and bringing the position to 69,815 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Brevan Howard Capital Management first reported a position in NVAX in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.82M in Q4 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Brevan Howard Capital Management held 69,815 shares of Novavax worth $658K as of Q2 2026.
  • Brevan Howard Capital Management bought 17,176 Novavax shares in Q2 2026, an estimated $154K.
  • Novavax made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1300 holding.
  • Brevan Howard Capital Management first reported a position in Novavax in Q2 2024 and has held it in 5 quarters since.
  • Brevan Howard Capital Management's Novavax position peaked at $1.82M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.